18
Venous Thromboembolism Prevention August 2010 August 2010

Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice Assess all patients upon admission to the ICU for

Embed Size (px)

Citation preview

Page 1: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembolism Prevention

August 2010August 2010

Page 2: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention2

Expected Practice

Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and anticipate orders for VTE prophylaxis based on risk assessment

Page 3: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention3

Expected Practice

Moderate-risk patients (medically ill and postoperative patients): low dose unfractionated heparin, low-molecular-weight heparin (LMWH), or fondaparinux

High risk patients (major trauma, spinal cord injury, or orthopedic surgery): LMWH, fondaparinux, or oral vitamin K antagonist

Page 4: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention4

Expected Practice

Patients with high risk for bleeding: mechanical prophylaxis

Graduated compression stockings Intermittent pneumatic compression devices

Mechanical prophylaxis may also be anticipated in conjunction with anti-coagulant based prophylaxis regimens

Page 5: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention5

Expected Practice

Review daily each patient’s current VTE risk factors including

clinical status necessity for central venous catheter current status of VTE prophylaxis risk for bleeding response to treatment.

Page 6: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention6

Expected Practice

Maximize patient mobility to reduce the amount of time the patient is immobile

Ensure that mechanical prophylaxis devices are fitted properly and in use at all times

Page 7: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention7

Problem Scope and Impact

Most hospitalized patients have at least one risk factor for VTE.

VTE is common and contributes to excess length of stay, excess charges, and mortality.

Primary thromboprophylaxis reduces the morbidity and mortality associated with deep vein thrombosis and pulmonary embolism.

Page 8: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention8

Supporting Evidence The majority of critical care patients have one or more risk

factors leading to VTE formation Immobilization sedation/neuromuscular blockade CVC’s Surgery sepsis mechanical ventilation vasopressor administration heart failure Stroke Malignancy previous VTE renal dialysis

Page 9: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention9

Supporting Evidence

Signs and symptoms of VTE are frequently silent and can lead to fatal pulmonary embolism, VTE prophylaxis is recommended for at-risk patients.

Page 10: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention10

Supporting Evidence

Low dose unfractionated heparin and LMWH are efficacious in preventing VTE in moderate-risk critical care patients.

For patients at higher risk major trauma or post orthopedic surgery, LMWH has been shown to provide superior protection over low dose unfractionated heparin.

Direct thrombin inhibitors can be used in place of low molecular weight heparin or unfractionated heparin in patients with heparin induced thrombocytopenia.

Page 11: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention11

Supporting Evidence

Mechanical methods of prophylaxis have been shown to reduce the risk of VTE

graduated compression stockings intermittent compression devices venous foot pumps

Mechanical prophylaxis is less efficacious when compared to anticoagulation based therapy.

Mechanical prophylaxis methods do not pose bleeding concerns.

Page 12: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention12

Supporting EvidenceWritten policies for VTE prophylaxis along

with either standing ICU admission orders increase compliance with prophylaxis measures

A daily goals form, which included VTE prophylaxis, resulted in a significant improvement in increased staff understanding the patient’s daily goals for care and decreased ICU length of stay

Page 13: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention13

Supporting Evidence

The presence of a CVC is a risk factor for upper extremity VTE population

Several studies identified immobility either as a co-morbidity or independent risk factor.

Compliance monitoring with intermittent pneumatic compression devices demonstrated rates of non-compliance ranging from 22% to 81% in at-risk patients

Page 14: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention14

Supporting Evidence

Improperly fitted compression stockings producing a reversed pressure gradient were associated with a significantly higher incidence of VTE compared with stockings that were properly fitted

Page 15: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention15

Actions for Nursing Practice

Ensure that your unit has a written policy for VTE prophylaxis that is updated regularly to reflect emerging evidentiary findings

Ensure that preprinted or computerized admission orders are available and current

Ensure that your unit has an organized process for developing and communicating patient goals (including VTE prophylaxis) to members of the multidisciplinary team

Page 16: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention16

Actions for Nursing Practice

Educate and routinely evaluate all staff in the use of mechanical prophylaxis devices

Review orders of patients discharged from the ICU to ensure a continuation plan for VTE prophylaxis

Page 17: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention17

Actions for Nursing Practice

Monitor compliance with VTE prophylaxis policies rates of VTE and pulmonary embolism initiate quality improvement initiatives

Page 18: Venous Thromboembolism Prevention August 2010. Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for

Venous Thromboembloism Prevention18

For more information or further assistance, please contact a clinical practice specialist with the AACN Practice Resource Network.

Need More Information?

Email:[email protected]